Clinical Trials Directory

Trials / Completed

CompletedNCT00156026

Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1

Randomized Trial of Immediate Treatment vs. Colposcopic Follow-up for Biopsy-Proven CIN 1

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
415 (actual)
Sponsor
Ontario Clinical Oncology Group (OCOG) · Academic / Other
Sex
Female
Age
16 Years
Healthy volunteers
Not accepted

Summary

This study looks at immediate treatment of a cervix with CIN 1 versus regular six-month follow-up with colposcopy and treatment if CIN 1 progresses.

Detailed description

In women who present with biopsy-proven CIN 1, to compare the management approach of regular colposcopic follow-up and only treating progressive disease using the LEEP, with an approach of immediate treatment using LEEP. The primary outcome is progression to more advanced disease (i.e., CIN 2, CIN 3 or cancer).

Conditions

Interventions

TypeNameDescription
PROCEDUREloop electrosurgical excision procedure (LEEP)1\. loop electrosurgical excision procedure

Timeline

Start date
2000-11-01
Primary completion
2007-09-01
Completion
2007-09-01
First posted
2005-09-12
Last updated
2009-01-29

Locations

10 sites across 2 countries: Brazil, Canada

Source: ClinicalTrials.gov record NCT00156026. Inclusion in this directory is not an endorsement.

Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1 (NCT00156026) · Clinical Trials Directory